Sonavex

Private

Baltimore, MarylandHealthcare & Life Scienceshttps://sonavex.com/

Last Round

Series A

Extension

Oct 24, 2024

Total Funding Raised

$27.15M

Company Overview

Sonavex is a medical device company that develops automated 3D ultrasound solutions designed to provide quantitative blood flow and vascular data at the point of care.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Medical AI, Healthcare Analytics

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Government Contracts

AI Layer

Application

Keywords

automated 3D ultrasoundmedical deviceAI-powered ultrasoundpoint of care ultrasoundPOCUSMedTechblood flow measurementmedical AIAV fistula maturationvascular accessbioresorbable implantultrasound markercannulation guidancemedical imagingpost-surgical monitoringFDA 510(k) clearance

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Sonavex Comparables

Compare Sonavex with similar companies based on industry and business-model similarity.

Sonavex comparables — related companies by embedding similarity
Company	Similarity	Market Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Sonavex Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A Extension	Oct 24, 2024
VC Round	Oct 24, 2024
Grant	Sep 25, 2024
Grant	May 25, 2022
VC Round	Nov 5, 2019
Grant	Aug 29, 2019

View all Funding Rounds

Key People

Founding team and executive leadership

David Narrow

CEO

Executive Team

Sonavex Investors

Notable investors and investment history

Sonavex investors
Investor	Rounds
Grey Sky Venture Partners	Series A
GenHenn Capital	Series A Extension
Fusion Fund	Series A
JSTAR Capital Investments	Series A Extension
Abell Foundation	Series A
NIH RADx	Grant
TEDCO	Convertible Debt, Series A, VC Round

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

May 4, 2025
Monthly visitors grew 71% MoM, reaching 2.4K.
Oct 29, 2024
Monthly visitors increased 36% MoM.

View all signals

Sonavex Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Sonavex Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Sonavex's valuation, stock price, and market status.

Firmographic Details

HeadquartersBaltimore, Maryland

Employee Range24

Year Founded2013

Last FundingOct 24, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.